RL vs SER · P/E 24, rev $8.11B vs rev $56.0K
Ralph Lauren Corp Class A (RL) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
RL currently screens at market cap $16.95B and trailing P/E 24.1. SER currently screens at market cap $29.7M.
Not investment advice. Open the RL and SER stock pages for the full models.
Not investment advice.